[
Abstract]
[
Full Text PDF] (in Japanese / 8128KB)
[Members Only And Two Factor Auth.]
J.Jpn. Surg. Soc.. 89(8): 1155-1166, 1988
Original article
AN EXPERIMENTAL ATTEMPT TO POTENTIATE THERAPEUTIC EFFECTS OF COMBINED USE OF PULSING MAGNETIC FIELDS AND ANTITUMOR AGENTS
With a view to examining the possible clinical applicability of pulsing magnetic fields (PMF), we investigated the effects of weak, non-heat inducing, PMF on DNA synthesis and sensitivity of cancer cells to antitum or agents.
Leukemic T-cells (Molt-4) and a pancreatic ductal adenocarcinoma (solid tumor) transplanted in a Syrian golden hamster were used for the in vitro experiment and in vivo experiment respectively. In order to evaluate the effects of PMF on the DNA synthesis of cancer cells and the incorporation of antitumor agent into cancer cells, cultured cells or solid tumor were exposed to PMF generated by a solenoid coil immediately after
3H-or
14C-thymidine and
3H-methotrexate administration respectively. Thymidine uptake was found to increase by exposure to PMF, as did also
3H-methotrexate uptake by leukemic T-cells. Following exposure to PMF immediately after administration of methotrexate or mitomycin C, antitumor activity in both cells was increased.
From these results it appears that the incorporation of antitumor agents into the cells increases by eddy current stimulation induced by PMF, and that the cell cycle shifts from the non-proliferative to proliferative phase, resulting in increased antitumor activity.
To read the PDF file you will need Adobe Reader installed on your computer.